As part of Open Journals’ initiatives, we create website for scholarly open access journals.
If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at
https://ejournalplus.com or send us an email to info@ejournalplus.com
Background: Direct laryngoscopy followed by endotracheal intubation is prone to haemodynamic fluctuations which may be detrimental in subjects with coronary artery disease, hypertension, and cerebral vascular disease. The aim is we wanted to compare Dexmedetomidine with Magnesium sulphate to determine the better drug with regard to attenuation of the haemodynamic responses during laryngoscopy and endotracheal intubation.
(2022). Dexmedetomidine 0.6 mcg/kg versus Magnesium Sulphate 50% 30 mg/kg for attenuation of Intubation Response. European Journal of Molecular & Clinical Medicine, 9(3), 814-824.
Velagalaburre Yalappa Srinivas, Mathikere Boregowda Sudarshan, Vivek Nayak, Kuzhippailil Vinod Kumar Harikrishnan, Narendra Babu Gowdagere Nagarajaiah. "Dexmedetomidine 0.6 mcg/kg versus Magnesium Sulphate 50% 30 mg/kg for attenuation of Intubation Response". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 814-824.
(2022). 'Dexmedetomidine 0.6 mcg/kg versus Magnesium Sulphate 50% 30 mg/kg for attenuation of Intubation Response', European Journal of Molecular & Clinical Medicine, 9(3), pp. 814-824.
Dexmedetomidine 0.6 mcg/kg versus Magnesium Sulphate 50% 30 mg/kg for attenuation of Intubation Response. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 814-824.
